557
Views
26
CrossRef citations to date
0
Altmetric
Article

Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis – a long-term follow-up study in 634 Swedish patients

, , , , , , , , , , , & show all
Pages 217-223 | Received 04 Sep 2014, Accepted 26 Oct 2014, Published online: 08 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Emma Nilsson, Harald Anderson, Konstantina Sargenti, Stefan Lindgren & Hanne Prytz. (2019) Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based study. Scandinavian Journal of Gastroenterology 54:8, pages 1027-1032.
Read now
Einar S. Björnsson & Anders Ekbom. (2015) Scandinavian epidemiological research in gastroenterology and hepatology. Scandinavian Journal of Gastroenterology 50:6, pages 636-648.
Read now

Articles from other publishers (24)

Rishi Bolia & Anshu Srivastava. (2022) Editorial: testing for Epstein‐Barr virus and treating autoimmune hepatitis—still a long way to go!. Alimentary Pharmacology & Therapeutics 55:3, pages 364-365.
Crossref
Rajani Sharma, Elizabeth C Verna, Tracey G Simon, Jonas Söderling, Hannes Hagström, Peter H R Green & Jonas F Ludvigsson. (2022) Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology. American Journal of Epidemiology 191:2, pages 298-319.
Crossref
Morten D. Jensen, Peter Jepsen, Hendrik Vilstrup & Lisbet Grønbæk. (2022) Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study. American Journal of Gastroenterology 117:1, pages 129-137.
Crossref
Nora V. Bergasa. 2022. Clinical Cases in Hepatology. Clinical Cases in Hepatology 85 122 .
Rajani Sharma, Elizabeth C. Verna, Jonas Söderling, Bjorn Roelstraete, Hannes Hagström & Jonas F. Ludvigsson. (2021) Increased Mortality Risk in Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology. Clinical Gastroenterology and Hepatology 19:12, pages 2636-2647.e13.
Crossref
John Kim, Harkanwal Randhawa, David Sands, Shahid Lambe, Marco Puglia, Pablo E. Serrano & Jehonathan H. Pinthus. (2021) Muscle-Invasive Bladder Cancer in Patients with Liver Cirrhosis: A Review of Pertinent Considerations. Bladder Cancer 7:3, pages 261-278.
Crossref
Guiqiang Wang, Atsushi Tanaka, Hong Zhao, Jidong Jia, Xiong Ma, Kenichi Harada, Fu-Sheng Wang, Lai Wei, Qixia Wang, Ying Sun, Yuan Hong, Huiying Rao, Cumali Efe, George Lau, Diana Payawal, Rino Gani, Keith Lindor, Wasim Jafri, Masao Omata & Shiv Kumar Sarin. (2021) The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatology International 15:2, pages 223-257.
Crossref
Eirini I. Rigopoulou & George N. Dalekos. (2021) Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases. Cancers 13:5, pages 1023.
Crossref
Jennifer Berumen, Jacopo Baglieri, Tatiana Kisseleva & Kristin Mekeel. (2020) Liver fibrosis: Pathophysiology and clinical implications. WIREs Mechanisms of Disease 13:1.
Crossref
Albert J. Czaja. (2020) Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 51:12, pages 1286-1304.
Crossref
Diego Vergani, Ian R. Mackay & Giorgina Mieli-Vergani. 2020. The Autoimmune Diseases. The Autoimmune Diseases 1117 1147 .
Dermot Gleeson. (2019) Long‐Term Outcomes of Autoimmune Hepatitis. Clinical Liver Disease 14:1, pages 24-28.
Crossref
Emma Nilsson, Harald Anderson, Konstantina Sargenti, Stefan Lindgren & Hanne Prytz. (2019) Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patients. Alimentary Pharmacology & Therapeutics 49:11, pages 1421-1430.
Crossref
Laura Harrison & Dermot Gleeson. (2019) Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): Is it justified (and in whom and when)?. Liver International 39:4, pages 610-620.
Crossref
Kazuo Tarao, Akito Nozaki, Takaaki Ikeda, Akira Sato, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri & Katsuaki Tanaka. (2019) Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment. Cancer Medicine 8:3, pages 1054-1065.
Crossref
Giorgina Mieli-Vergani & Diego Vergani. 2019. Pediatric Hepatology and Liver Transplantation. Pediatric Hepatology and Liver Transplantation 175 199 .
Margarita N. German & Adnan Said. 2019. Gastrointestinal and Liver Disorders in Women’s Health. Gastrointestinal and Liver Disorders in Women’s Health 99 108 .
Giorgina Mieli-Vergani, Diego Vergani, Albert J. Czaja, Michael P. Manns, Edward L. Krawitt, John M. Vierling, Ansgar W. Lohse & Aldo J. Montano-Loza. (2018) Autoimmune hepatitis. Nature Reviews Disease Primers 4:1.
Crossref
Bo Hyun Kim, Hwa Young Choi, Moran Ki, Kyung-Ah Kim, Eun Sun Jang & Sook-Hyang Jeong. (2017) Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea. PLOS ONE 12:8, pages e0182391.
Crossref
Aylin Tansel, Lior H. Katz, Hashem B. El-Serag, Aaron P. Thrift, Mayur Parepally, Mohammad H. Shakhatreh & Fasiha Kanwal. (2017) Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 15:8, pages 1207-1217.e4.
Crossref
Shamir Cassim, Marc Bilodeau, Catherine Vincent & Pascal Lapierre. (2017) Novel Immunotherapies for Autoimmune Hepatitis. Frontiers in Pediatrics 5.
Crossref
Valery Hrad, Yoftahe Abebe, Syed Haris Ali, Jared Velgersdyk, Mohammed Al Hallak & Mohamad Imam. (2016) Risk and Surveillance of Cancers in Primary Biliary Tract Disease. Gastroenterology Research and Practice 2016, pages 1-9.
Crossref
John M. Vierling. (2015) Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management. Clinical Gastroenterology and Hepatology 13:12, pages 2088-2108.
Crossref
Zhi-Xian Chen, Jian-Guo Shao, Yi Shen, Jian Zhang, Yu Hua, Lu-Jun Wang & Gang Qin. (2015) Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis. Medicine 94:23, pages e953.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.